homoserine has been researched along with rosiglitazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryan, A; Do, C; Jahoor, A; Krier, J; Li, G; Patel, R; Rumbaugh, KP; Wahli, W; Watters, C; Williams, SC | 1 |
| Cooley, MA; Rolph, MS; Whittall, C | 1 |
2 other study(ies) available for homoserine and rosiglitazone
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptors mediate host cell proinflammatory responses to Pseudomonas aeruginosa autoinducer.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Cytokines; DNA; Electrophoretic Mobility Shift Assay; Homoserine; Humans; Inflammation Mediators; Lactones; Mice; NIH 3T3 Cells; Peroxisome Proliferator-Activated Receptors; PPAR gamma; PPAR-beta; Protein Binding; Pseudomonas aeruginosa; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Transcription, Genetic | 2008 |
Pseudomonas signal molecule 3-oxo-C12-homoserine lactone interferes with binding of rosiglitazone to human PPARgamma.
Topics: 4-Butyrolactone; Anti-Inflammatory Agents; Homoserine; Humans; PPAR gamma; Protein Binding; Pseudomonas aeruginosa; Rosiglitazone; Thiazolidinediones | 2010 |